Table 3 Clinical characteristics according to the presence or absence of PH in severe BPD
Severe BPD | |||
|---|---|---|---|
PH | Non-PH | P-values | |
(n = 17) | (n = 23) | ||
Gestational age, weeks | 25.3 ± 1.4 | 25.5 ± 1.0 | 0.470 |
Birth weight, g | 709.5 ± 195.5 | 744.0 ± 158.6 | 0.543 |
Birth weight < 10th percentile for age, n (%) | 5 (29.4) | 4 (17.4) | 0.456 |
Multiple birth, n (%) | 3 (17.6) | 14 (60.9) | 0.010 |
Cesarean section, n (%) | 12 (70.6) | 13 (56.5) | 0.512 |
Perinatal steroids administration, n (%) | 13 (76.5) | 17 (77.3) | 1.000 |
Chorioamnionitis, n (%) | 9 (52.9) | 11 (47.8) | 0.749 |
Preeclampsia, n (%) | 3 (18.8) | 2 (8.7) | 0.631 |
Oligohydramnios, n (%) | 4 (23.5) | 2 (8.7) | 0.373 |
RDS, n (%) | 14 (82.4) | 19 (82.6) | 1.000 |
Treated PDA, n (%) | 14 (82.4) | 18 (78.3) | 0.616 |
Culture proven sepsis, n (%) | 9 (52.9) | 8 (34.8) | 0.251 |
ROP operation, n (%) | 6 (35.3) | 14 (60.9) | 0.110 |
NEC operation, n (%) | 5 (31.2) | 3 (13.0) | 0.235 |
Length of stay, days | 115 (94–268) | 113 (77–163) | 0.448 |
Respiratory management | |||
Duration of CV or HFV, days | 72 (0–199) | 40 (6–148) | 0.090 |
BPD steroid, n (%) | 5 (29.4) | 6 (26.1) | 1.000 |
Dexamethasone cumulative dose (mg/kg) | 1.80 (1.10–3.23) | 1.10 (0.42–3.04) | 0.416 |
Discharge on oxygen, n (%) | 12 (70.6) | 15 (65.2) | 0.720 |
Total extra O2 supplementationa | 25,199 (1428–71,095) | 20,325 (11,417–46,362) | 0.434 |
Episodes of hypoxiab | 338 (172–1205) | 258 (57–696) | 0.254 |
Episodes of bradycardiac | 40 (8–216) | 56 (4–169) | 0.734 |